surmount-osa trial tirzepatide results VisualAbstract: Improved Outcomes in Patients with Obstructive Sleep Apnea and Obesity SURMOUNT-1 Trial - Cardionerds Twitter

Time dependence refers to the pattern of side effects being most prominent during treatment initiation and dose increases, then declining as the body adapts

Because retatrutide is still investigational, important unanswered questions remain about long-term cardiovascular effects, durability of weight loss, ongoing tolerability, and safety across broader patient populations, which is one reason reputable clinics, including Relive Health centers nationwide, are not offering retatrutide at this time

During the first month of semaglutide therapy, most patients experience modest weight losstypically 1-2% of baseline body weight, or approximately 2 to 5 poundsas the medication is initiated at lower doses

Do not us e the sam e injection sit e f or eac h injec tion

Taking time to eat slowly and stopping when you feel comfortably satisfiedrather than fullcan help prevent discomfort

You should think of this medication as a way to kick-start and accelerate weight loss